Home › Pancreatic Cancer › Arizona › Gilbert
Pancreatic Cancer clinical trials in Gilbert, AZ
5 studies for Pancreatic Cancer are looking for participants at sites in and around Gilbert (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
- Banner Health, Gilbert
CREO - Microwave Ablation Feasibility Study
Recruiting
- Banner MD Anderson Cancer Center and Gateway Hospital, Gilbert
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
Recruiting
- Banner MD Anderson Cancer Center, Gilbert
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RecruitingPhase 3
- Banner MD Anderson Cancer Center, Gilbert
- Arizona Center for Cancer Care - Gilbert, Gilbert
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecruitingPhase 1/2
- Banner Health, Gilbert
About Pancreatic Cancer
The pancreas is a gland behind your stomach that produces insulin. Pancreatic cancer is hard to catch early. Find out about risk factors and symptoms.
More about Pancreatic Cancer on MedlinePlus
Pancreatic Cancer trials in other cities
- Houston, TX61 studies
- New York City, NY60 studies
- Boston, MA43 studies
- Nashville, TN39 studies
- Los Angeles, CA35 studies
- St. Louis, MO33 studies
- Arlington, VA33 studies
- San Antonio, TX31 studies
- Baltimore, MD31 studies
- Tampa, FL26 studies
- Philadelphia, PA26 studies
- San Diego, CA24 studies
Other studies in Gilbert
- Non-Small Cell Lung Cancer12 studies
- Colorectal Cancer9 studies
- Breast Cancer9 studies
- Lung Cancer8 studies
- Cancer (all types)8 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Metastatic Cancer6 studies
- Multiple Myeloma6 studies
- Heart Failure6 studies
- Cardiovascular Disease6 studies
- Bladder Cancer6 studies
- Non-Hodgkin Lymphoma5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.